Dynamic and Label-Free Cell-Based Assays Using the xCELLigence System

Label-Free Technologies for Drug Discovery

Volumn , Issue , 2011, Pages 71-81

  Abassi, Yama A ^a   Sieler, Alexander ^b   Watzele, Manfred ^b   Wang, Xiaobo ^a   Xu, Xiao ^a  

^a ACEA Biosciences Inc   (United States)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Actual kinetic response of cells information regarding biological status of cells; Cell based assays of preclinical drug discovery process; Dynamic and label free cell based assays using the xCELLigence System; Impedance readout utilized by xCELLigence system affected by multiple parameters, cell number, adhesion and morphology; Label free cell based technologies implementation, in preclinical drug discovery settings; XCELLigence Real Time Cell Analysis (RT CA) system series of three instruments differing primarily in throughput capacity; XCELLigence System; XCELLigence system, and impedance readout noninvasively quantifying cellular status in real time

Indexed keywords

EID: 84856403899     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470979129.ch5     Document Type: Chapter

References (26)

1. K. Moore and S. Rees, J Biomol Screen 6, 69 (2001).
2. R. S. Hauptschein, B. K. Eustace and D. G. Jay, Exp Hematol 30, 381 (2002).
3. J. M. Atienza et al., Assay Drug Dev Technol 4, 597 (2006).
4. G. J. Ciambrone et al., J Biomol Screen 9, 467 (2004).
5. Y. Fang, Assay Drug Dev Technol 4, 583 (2006).
6. R. McGuinness, Curr Opin Pharmacol 7, 535 (2007).
7. E. Verdonk et al., Assay Drug Dev Technol 4, 609 (2006).
8. B. Xi et al., Biotechnol J 3, 484 (2008).
9. E. M. Denholm and G. P. Stankus, Cytometry 19, 366 (1995).
10. K. B. Abbitt, G. E. Rainger and G. B. Nash, J Immunol Methods 239, 109 (2000).
11. M. A. Cooper., Drug Discov Today 11, 1068 (2006).
12. I. Giaever and C. R. Keese, Nature 366, 591 (1993).
13. I. Giaever and C. R. Keese, IEEE Trans Biomed Eng 33, 242 (1986).
14. K. Solly et al., Assay Drug Dev Technol 2, 363 (2004).
15. D. Hanahan and R. A. Weinberg, Cell 100, 57 (2000).
16. J. Z. Xing et al., Chem Res Toxicol 18, 154 (2005).
17. S. L. Kirstein et al., Assay Drug Dev Technol 4, 545 (2006).
18. Y.A. Abassi, et al., Chem Biol 16, 712 (2009).
19. J. Glamann and A. J. Hansen, Assay Drug Dev Technol 4, 555 (2006).
20. Y. A. Abassi et al., J Immunol Methods 292, 195 (2004).
21. P. Nambi and N. Aiyar, Assay Drug Dev Technol 1, 305 (2003).
22. S. Siehler, Biotechnol J 3, 471 (2008).
23. R. A.Hall, R. T. Premont and R. J. Lefkowitz, J Cell Biol 145, 927 (1999).
24. M. Bhattacharya, A. V. Babwah and S. S. Ferguson, Biochem Soc Trans 32, 1040 (2004).
25. S. Etienne-Manneville and A. Hall, Nature 420, 629 (2002).
26. N. Yu et al., Anal Chem 78, 35 (2006).